| Known as |
amlexanox |
ClinicalTrials.gov intervention name — accepted as the source's own label NCT01083875 ↗2NCT01975935 ↗ NCT01842282 ↗
|
| Known as |
AA-673 |
ChEMBL registry synonym — accepted as the source's own label CHEMBL1096 ↗
|
| Known as |
Amlexanoxo |
ChEMBL registry synonym — accepted as the source's own label CHEMBL1096 ↗
|
| Known as |
Amoxanox |
ChEMBL registry synonym — accepted as the source's own label CHEMBL1096 ↗
|
| Known as |
Aphthasol |
ChEMBL registry synonym — accepted as the source's own label CHEMBL1096 ↗
|
| Known as |
Aphtheal |
ChEMBL registry synonym — accepted as the source's own label CHEMBL1096 ↗
|
| Known as |
CHX 3673 |
ChEMBL registry synonym — accepted as the source's own label CHEMBL1096 ↗
|
| Known as |
Elics |
ChEMBL registry synonym — accepted as the source's own label CHEMBL1096 ↗
|
| Known as |
Solfa |
ChEMBL registry synonym — accepted as the source's own label CHEMBL1096 ↗
|
| Action |
Inhibit |
“the most potent and specific inhibitor discovered was amlexanox” NCT01975935 ↗
|
| Modality |
Small molecule |
— CHEMBL1096 ↗
|
| Route |
Oral |
“0.5% amlexanox oral rinse” NCT01083875 ↗
|